Cargando…
Feasibility and outcome of metacognitive therapy for major depressive disorder: a pilot study
BACKGROUND: Several studies have shown the effectiveness of Metacognitive Therapy (MCT) in treating different mental disorders. Most of these studies were performed in English speaking countries using the original English version of the manual. Our study aimed to examine the feasibility of the trans...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690014/ https://www.ncbi.nlm.nih.gov/pubmed/33243217 http://dx.doi.org/10.1186/s12888-020-02976-4 |
_version_ | 1783613981942874112 |
---|---|
author | Winter, Lotta Schweiger, Ulrich Kahl, Kai G. |
author_facet | Winter, Lotta Schweiger, Ulrich Kahl, Kai G. |
author_sort | Winter, Lotta |
collection | PubMed |
description | BACKGROUND: Several studies have shown the effectiveness of Metacognitive Therapy (MCT) in treating different mental disorders. Most of these studies were performed in English speaking countries using the original English version of the manual. Our study aimed to examine the feasibility of the translated MCT manual in a sample of German patients with major depressive disorder. METHODS: Twenty outpatients (6 male, 14 female, mean age 42.1y) with major depressive disorder were included. The main outcome was drop-out rate and satisfaction with the treatment; secondary outcomes were changes in metacognitive beliefs assessed with the metacognitive questionnaire 30 (MCQ-30), and symptom reduction measured with the Beck Depression Inventory-2 sum score (BDI-2). RESULTS: No drop-outs during the treatment and the follow-up phase were observed. Patients and therapists were highly satisfied with MCT treatment. The MCQ-30 significantly declined over the treatment course, paralleled by a significant reduction of the BDI-2 sum scores (from 29 ± 8.6 at T0 to 8.4 ± 9.6 at the end of treatment). The average treatment duration was 10 ± 4 sessions. CONCLUSIONS: Applying the German version of the manual for Metacognitive Therapy proved to be feasible in the treatment of depressed patients in an outpatient setting. The treatment was well tolerated by German patients. Outcome in terms of reduction of depressive symptoms was good. Remarkable is the comparably short treatment duration which should be investigated further in future studies. TRIAL REGISTRATION: German Clinical Trials Register (DRKS): DRKS00023644, 17.11.2020 (retrospectively registered). |
format | Online Article Text |
id | pubmed-7690014 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76900142020-11-30 Feasibility and outcome of metacognitive therapy for major depressive disorder: a pilot study Winter, Lotta Schweiger, Ulrich Kahl, Kai G. BMC Psychiatry Research Article BACKGROUND: Several studies have shown the effectiveness of Metacognitive Therapy (MCT) in treating different mental disorders. Most of these studies were performed in English speaking countries using the original English version of the manual. Our study aimed to examine the feasibility of the translated MCT manual in a sample of German patients with major depressive disorder. METHODS: Twenty outpatients (6 male, 14 female, mean age 42.1y) with major depressive disorder were included. The main outcome was drop-out rate and satisfaction with the treatment; secondary outcomes were changes in metacognitive beliefs assessed with the metacognitive questionnaire 30 (MCQ-30), and symptom reduction measured with the Beck Depression Inventory-2 sum score (BDI-2). RESULTS: No drop-outs during the treatment and the follow-up phase were observed. Patients and therapists were highly satisfied with MCT treatment. The MCQ-30 significantly declined over the treatment course, paralleled by a significant reduction of the BDI-2 sum scores (from 29 ± 8.6 at T0 to 8.4 ± 9.6 at the end of treatment). The average treatment duration was 10 ± 4 sessions. CONCLUSIONS: Applying the German version of the manual for Metacognitive Therapy proved to be feasible in the treatment of depressed patients in an outpatient setting. The treatment was well tolerated by German patients. Outcome in terms of reduction of depressive symptoms was good. Remarkable is the comparably short treatment duration which should be investigated further in future studies. TRIAL REGISTRATION: German Clinical Trials Register (DRKS): DRKS00023644, 17.11.2020 (retrospectively registered). BioMed Central 2020-11-26 /pmc/articles/PMC7690014/ /pubmed/33243217 http://dx.doi.org/10.1186/s12888-020-02976-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Winter, Lotta Schweiger, Ulrich Kahl, Kai G. Feasibility and outcome of metacognitive therapy for major depressive disorder: a pilot study |
title | Feasibility and outcome of metacognitive therapy for major depressive disorder: a pilot study |
title_full | Feasibility and outcome of metacognitive therapy for major depressive disorder: a pilot study |
title_fullStr | Feasibility and outcome of metacognitive therapy for major depressive disorder: a pilot study |
title_full_unstemmed | Feasibility and outcome of metacognitive therapy for major depressive disorder: a pilot study |
title_short | Feasibility and outcome of metacognitive therapy for major depressive disorder: a pilot study |
title_sort | feasibility and outcome of metacognitive therapy for major depressive disorder: a pilot study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690014/ https://www.ncbi.nlm.nih.gov/pubmed/33243217 http://dx.doi.org/10.1186/s12888-020-02976-4 |
work_keys_str_mv | AT winterlotta feasibilityandoutcomeofmetacognitivetherapyformajordepressivedisorderapilotstudy AT schweigerulrich feasibilityandoutcomeofmetacognitivetherapyformajordepressivedisorderapilotstudy AT kahlkaig feasibilityandoutcomeofmetacognitivetherapyformajordepressivedisorderapilotstudy |